OSMA Guidance’s One-Year Follow-Up For Hip Studies Gains Panel Support
This article was originally published in The Gray Sheet
Executive Summary
FDA's Orthopedic & Rehabilitation Devices Panel recommends radiographic evaluation, such as x-ray, as an endpoint in hip prosthesis clinical studies if follow-up is limited to one year